Trial results

$KARD — ataciguat

Kardigan, Inc. (KARD) ataciguat: trial results in aortic stenosis, 2026.

Research by Catalyst Intel

The catalyst

"Topline data from the Phase 2b trial is currently expected in the second half of 2026."

— Kardigan, Inc., 8-K filed 2026-11-06 · the filing. Checked word for word against the stored document when this page was built; a sentence that did not check out would not be here.

Event id

KARD-ATACIGUAT-2026

Company

Kardigan, Inc.

Kind

Trial results

Indication

aortic stenosis

Window

2026-07-01 – 2026-12-31

Status

dropped

The bar

No bar has been published for this event yet.

Verdicts

No verdict has been published for this event yet.